Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Financial Info > Press Releases
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
COVANCE TO PRESENT AT THE GOLDMAN SACHS TWENTY FOURTH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Princeton, New Jersey, June 6, 2003 — Covance Inc. (NYSE: CVD) will participate in Goldman Sachs Twenty Fourth Annual Global Healthcare Conference in Laguna Niguel, California on Tuesday, June 10, 2003 at 2:40 p.m. PDT. Bill Klitgaard, Covance's Chief Financial Officer, will make a formal presentation at the event.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2002 net revenues of $883 million, global operations in 18 countries, and approximately 6,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area.
SEC Filings
Annual Reports
Quarterly Reports
Press Releases